Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

NCT04562532 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

1720

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Microport Firehawk stent
DEVICE: 2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)

Sponsor

Shanghai MicroPort Medical (Group) Co., Ltd.